Cefodizime Sodium ≥96% (HPLC); CAS Number: ; Synonym: 5-Thia azabicyclo[]octenecarboxylic acid. Cefodizime Sodium is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cefodizime Sodium is available on the. The first dose of cefodizime in patients with impaired renal function is the . The sodium content of cefodizime (75 mg/g) should be taken into.

Author:	Gazahn Zolojora
Country:	Zambia
Language:	English (Spanish)
Genre:	Education
Published (Last):	16 April 2012
Pages:	256
PDF File Size:	17.9 Mb
ePub File Size:	16.73 Mb
ISBN:	958-6-18032-891-3
Downloads:	54322
Price:	Free* [*Free Regsitration Required]
Uploader:	Kajilmaran

Succinic acid The excretion of Succinic acid can be decreased when combined with Cefotaxime. Diclofenac The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Diclofenac. Pentobarbital Cefotaxime may decrease the excretion rate of Pentobarbital which could result in a higher serum level.

Florbetapir 18F Cefotaxime may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level. Magnesium carbonate Cefotaxime may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.

Pitolisant Cefotaxime may decrease the excretion rate of Pitolisant which could result in a higher serum level. Toloxatone Cefotaxime may decrease the excretion rate of Toloxatone which could result in a higher serum level. Valganciclovir Cefotaxime may decrease the excretion rate of Valganciclovir which could result in a higher serum level. Mefenamic acid The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Mefenamic acid.

Tinzaparin The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Cefotaxime. Cefdinir The excretion of Cefdinir can be decreased when combined with Cefotaxime.

Amikacin The risk or severity of nephrotoxicity can be increased when Amikacin is combined with Cefotaxime. Oxyquinoline Cefotaxime may decrease the excretion rate of Oxyquinoline which could result in a higher serum level. Dacarbazine Cefotaxime may decrease the excretion rate of Dacarbazine which could result in a higher serum level. Tobramycin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Tobramycin.

Tasimelteon Cefotaxime may decrease the excretion rate of Tasimelteon which could result in a higher serum level. Phenylbutazone The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Phenylbutazone.

Pidotimod Cefotaxime may decrease the excretion rate of Pidotimod which could result in a higher serum level. Amediplase The therapeutic efficacy of Amediplase can be decreased when used in combination with Cefotaxime. Triazolam Cefotaxime may decrease the excretion rate of Triazolam which could result in a higher serum level. Human rabies virus immune globulin The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Cefotaxime.

Cefminox The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefminox. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Ketoprofen Cefotaxime may sodihm the excretion rate of Ketoprofen which could result in a higher serum level. Eucalyptus oil Cefotaxime may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.

Cefodizime Sodium –

Fenoprofen The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Fenoprofen. Hydrolyzed Cephalothin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Hydrolyzed Cephalothin. Clinically, it has been shown to be effective against upper and lower respiratory tract infections, urinary tract infections, and gonorrhea. Otamixaban The therapeutic efficacy of Otamixaban can be decreased when used in combination with Cefotaxime.

Flunixin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Flunixin.

Mercaptopurine The excretion of Mercaptopurine can be sodiuk when combined with Cefotaxime. Cefadroxil Cefotaxime may decrease the excretion rate of Cefadroxil which could result in a higher serum level. Roflumilast Cefotaxime may decrease the excretion rate of Roflumilast which could result in a higher serum level. N-Methylnicotinamide Cefotaxime may decrease the excretion sodoum of N-Methylnicotinamide which could result in a higher serum level.

Difenpiramide The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Difenpiramide. Ticagrelor The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Cefotaxime.

Clozapine Cefotaxime may decrease the excretion rate of Clozapine which could result in a higher serum level. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. Piracetam Cefotaxime may decrease the excretion rate of Piracetam which could result in a higher serum level. Ifosfamide Cefotaxime may decrease the excretion rate of Ifosfamide which could result in a higher serum level.

Cefodizime Sodium

Lubiprostone Cefotaxime may decrease the excretion rate of Lubiprostone which could result in a higher serum level. Ceftibuten Cefotaxime may decrease the excretion rate of Ceftibuten which could result in a higher serum level. Deutetrabenazine Cefotaxime may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. Drug created on June 13, Deferiprone Cefotaxime may decrease the excretion rate of Deferiprone which could result in a higher serum level.

Plerixafor Cefotaxime may decrease the excretion rate of Plerixafor which could result in a higher serum level. Lorcaserin Cefotaxime may decrease the excretion rate of Lorcaserin which could result in a higher serum level.

Pentetic acid Cefotaxime may decrease the excretion rate of Pentetic acid which could result in a higher serum level. Tocopherol Cefotaxime may decrease the excretion rate of Tocopherol which could result in a higher serum level. Abacavir Cefotaxime may decrease the excretion rate of Abacavir which could result in a higher serum level.